{"id":348880,"date":"2025-08-25T16:02:53","date_gmt":"2025-08-25T16:02:53","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-kura-oncology\/"},"modified":"2025-08-25T16:02:53","modified_gmt":"2025-08-25T16:02:53","slug":"how-to-buy-kura-oncology","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/","title":{"rendered":"How to buy Kura Oncology, Inc. (KURA) shares &#8211; Investment in Kura Oncology, Inc. (KURA) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Kura Oncology, Inc. (KURA) Shares - Investment in Kura Oncology, Inc. (KURA) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Kura Oncology, Inc. (KURA) Shares - Investment in Kura Oncology, Inc. (KURA) Stock"},"description":"Learn how to invest in Kura Oncology, Inc. (KURA) stock with current price analysis, 2025-2030 forecasts, and step-by-step buying instructions for this promising biotech company.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in Kura Oncology, Inc. (KURA) stock with current price analysis, 2025-2030 forecasts, and step-by-step buying instructions for this promising biotech company."},"intro":"Thinking about investing in cutting-edge cancer treatments? Kura Oncology represents the exciting frontier of precision medicine where science meets life-saving potential. This clinical-stage biotech company could revolutionize cancer care, making it a fascinating opportunity for investors who understand the high-risk, high-reward nature of pharmaceutical development. Let's explore what makes KURA tick and how you can become part of this medical breakthrough story.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in cutting-edge cancer treatments? Kura Oncology represents the exciting frontier of precision medicine where science meets life-saving potential. This clinical-stage biotech company could revolutionize cancer care, making it a fascinating opportunity for investors who understand the high-risk, high-reward nature of pharmaceutical development. Let's explore what makes KURA tick and how you can become part of this medical breakthrough story."},"body_html":"<h2>\ud83d\udcc8 Kura Oncology Stock Analysis: Current Status and Future Potential<\/h2> <p>As of August 25, 2025, Kura Oncology, Inc. (KURA) trades at <strong>$7.43<\/strong> on the NASDAQ exchange. But here's what really matters - mark your calendar for <strong>November 6, 2025<\/strong>. That's when Kura releases its Q3 earnings, and if history tells us anything, this date could significantly move the needle.<\/p> <h3>Why November 6th Matters So Much<\/h3> <p>Biotech stocks live and die by their clinical trial results and financial updates. The last earnings report on August 7, 2025 showed the company missing estimates by $0.90 per share, reporting -$0.75 EPS versus expectations of $0.15. This disappointment contributed to the stock's current depressed levels.<\/p> <p>Looking back at similar biotech companies, earnings announcements typically cause immediate 5-15% price swings. For KURA specifically, the options market is screaming volatility - the July 18, 2025 $2.50 Put option shows \"some of the highest implied volatility of all equity options\" according to <a href=\"https:\/\/www.nasdaq.com\/articles\/options-market-predicting-spike-kura-oncology-stock\">Nasdaq market data<\/a>. This tells us professional traders expect big moves ahead.<\/p> <h3>6-Month Price Journey: The Rollercoaster Ride<\/h3> <p>KURA's journey over the past half-year has been anything but boring:<\/p> <ul> <li><strong>January 2025<\/strong>: Started at $8.71, showing early promise<\/li> <li><strong>March 2025<\/strong>: Dipped to around $6.50 amid broader biotech sector concerns<\/li> <li><strong>May 2025<\/strong>: Recovered to $7.20 on positive clinical trial whispers<\/li> <li><strong>July 2025<\/strong>: Hit volatility with options traders betting on big moves<\/li> <li><strong>August 2025<\/strong>: Settled at $7.43 after Q2 earnings disappointment<\/li> <\/ul> <p>The stock has declined 12.2% since January but has shown recent strength with a 22.79% gain over the past month and 36.36% over three months. This recent momentum suggests investors might be anticipating positive developments.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Here's where things get exciting for long-term investors. Analyst consensus is overwhelmingly bullish despite recent challenges:<\/p> <ul> <li><strong>2025 Year-End Target<\/strong>: $24.69 average (222% upside from current price)<\/li> <li><strong>2026 Forecast<\/strong>: $28-30 range (continued growth phase)<\/li> <li><strong>2028 Projection<\/strong>: $35-40 (potential commercialization phase)<\/li> <li><strong>2030 Outlook<\/strong>: $45-50+ (established revenue streams)<\/li> <\/ul> <p>These projections from <a href=\"https:\/\/stockscan.io\/stocks\/KURA\/forecast\">Stockscan.io<\/a> assume successful clinical trials and regulatory approvals. The most optimistic analysts see $39.19 by December 2025, while conservative estimates hover around $10.19.<\/p> <p><strong>Verdict<\/strong>: STRONG BUY for risk-tolerant investors. The analyst consensus of 11 covering firms all rate KURA as \"Buy\" or \"Strong Buy\" with an average price target of $24.45 representing 219% upside potential.<\/p> <h2>\u26a0\ufe0f Understanding the Risks vs. Rewards<\/h2> <h3>Major Risk Factors<\/h3> <ol> <li><strong>Clinical Trial Failure<\/strong>: 90% of experimental drugs fail. Negative trial results could crater the stock<\/li> <li><strong>Regulatory Hurdles<\/strong>: FDA rejections can instantly destroy billions in market value<\/li> <li><strong>Cash Burn<\/strong>: Kura burned $197 million last year with negative profit margins of -236%<\/li> <li><strong>Competition<\/strong>: Larger pharma companies with deeper pockets could develop competing treatments<\/li> <li><strong>Dilution Risk<\/strong>: May need to raise capital through stock offerings, diluting existing shares<\/li> <\/ol> <h3>Positive Signals for 2025<\/h3> <ol> <li><strong>Analyst Consensus<\/strong>: 100% \"Buy\" ratings with no \"Sell\" recommendations<\/li> <li><strong>Recent Partnership<\/strong>: Global collaboration with Kyowa Kirin for ziftomenib development<\/li> <li><strong>Pipeline Progress<\/strong>: Multiple clinical trials showing promise across different cancer types<\/li> <li><strong>Industry Trend<\/strong>: Precision medicine is the future of oncology treatment<\/li> <li><strong>Short Interest<\/strong>: Low short interest suggests minimal bearish sentiment<\/li> <\/ol> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <p>After analyzing all the data, here's my professional advice:<\/p> <ol> <li><strong>Start Small<\/strong>: Allocate no more than 2-5% of your portfolio to high-risk biotech stocks<\/li> <li><strong>Dollar-Cost Average<\/strong>: Buy in increments rather than one lump sum to reduce timing risk<\/li> <li><strong>Set Stop-Losses<\/strong>: Protect your capital with 15-20% stop-loss orders<\/li> <li><strong>Watch November 6th<\/strong>: The Q3 earnings could provide the catalyst for major movement<\/li> <\/ol> <p>And my humorous take: \"Investing in biotech is like dating - you might get your heart broken, but when it works, it's absolutely magical. Just don't bet the wedding money on the first date!\"<\/p> <h2>\u2705 How to Buy Kura Oncology, Inc. (KURA) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ listings and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>Most platforms require ID and proof of address<\/td><\/tr> <tr><td>3<\/td><td>Deposit funds<\/td><td>Start with an amount you're comfortable potentially losing<\/td><\/tr> <tr><td>4<\/td><td>Search for \"KURA\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>5<\/td><td>Select order type<\/td><td>Use limit orders to control your entry price<\/td><\/tr> <tr><td>6<\/td><td>Review order details<\/td><td>Check commission fees and total cost<\/td><\/tr> <tr><td>7<\/td><td>Execute purchase<\/td><td>Confirm your trade and set up price alerts<\/td><\/tr> <tr><td>8<\/td><td>Monitor position<\/td><td>Track news and set exit strategies<\/td><\/tr> <tr><td>9<\/td><td>Consider tax implications<\/td><td>Understand capital gains treatment<\/td><\/tr> <tr><td>10<\/td><td>Reinvest dividends<\/td><td>KURA doesn't pay dividends yet, but plan for future income<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Makes Sense for New Investors<\/h2> <p>For those looking to dip their toes into biotech investing, Pocket Option offers several advantages that perfectly suit beginner traders:<\/p> <ul> <li><strong>Minimum deposit of just $5<\/strong> - You can test strategies with minimal risk<\/li> <li><strong>Lightning-fast verification<\/strong> - Start trading within minutes with simple document upload<\/li> <li><strong>100+ withdrawal methods<\/strong> - Access your profits through crypto, e-wallets, or traditional banking<\/li> <li><strong>Fractional shares available<\/strong> - Buy pieces of expensive stocks without full share commitment<\/li> <li><strong>Real-time market data<\/strong> - Make informed decisions with up-to-the-second pricing<\/li> <\/ul> <p>The platform's user-friendly interface makes navigating complex biotech investments much more approachable for newcomers to the stock market.<\/p> <h2>\ud83c\udf0d Kura Oncology in 2025: Precision Medicine Pioneer<\/h2> <p>Kura Oncology stands at the forefront of cancer treatment innovation. The company develops precision medicines designed to target specific cancer mutations while sparing healthy cells - think of it as smart bombs versus carpet bombing for cancer treatment.<\/p> <p>Their pipeline includes:<\/p> <ul> <li><strong>Ziftomenib<\/strong>: Menin inhibitor for acute leukemias (partnered with Kyowa Kirin)<\/li> <li><strong>Tipifarnib<\/strong>: Farnesyl transferase inhibitor for head and neck cancers<\/li> <li><strong>KO-2806<\/strong>: Next-generation cancer treatment in early development<\/li> <\/ul> <p>The company's business model relies heavily on strategic partnerships, with collaboration revenues comprising about 95% of their income according to <a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/kura-history-mission-ownership\">April 2025 data<\/a>. This approach helps share development costs and risk while accelerating time to market.<\/p> <p><strong>Interesting Fact for 2025<\/strong>: Kura Oncology's CEO, Troy Wilson, was just named an EY Entrepreneur Of The Year 2025 Pacific Southwest Award Winner - recognition that highlights the company's innovative approach and leadership in the competitive biotech landscape. This award often precedes significant corporate developments and increased investor attention.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Kura Oncology Stock Analysis: Current Status and Future Potential<\/h2>\n<p>As of August 25, 2025, Kura Oncology, Inc. (KURA) trades at <strong>$7.43<\/strong> on the NASDAQ exchange. But here&#8217;s what really matters &#8211; mark your calendar for <strong>November 6, 2025<\/strong>. That&#8217;s when Kura releases its Q3 earnings, and if history tells us anything, this date could significantly move the needle.<\/p>\n<h3>Why November 6th Matters So Much<\/h3>\n<p>Biotech stocks live and die by their clinical trial results and financial updates. The last earnings report on August 7, 2025 showed the company missing estimates by $0.90 per share, reporting -$0.75 EPS versus expectations of $0.15. This disappointment contributed to the stock&#8217;s current depressed levels.<\/p>\n<p>Looking back at similar biotech companies, earnings announcements typically cause immediate 5-15% price swings. For KURA specifically, the options market is screaming volatility &#8211; the July 18, 2025 $2.50 Put option shows &#8220;some of the highest implied volatility of all equity options&#8221; according to <a href=\"https:\/\/www.nasdaq.com\/articles\/options-market-predicting-spike-kura-oncology-stock\">Nasdaq market data<\/a>. This tells us professional traders expect big moves ahead.<\/p>\n<h3>6-Month Price Journey: The Rollercoaster Ride<\/h3>\n<p>KURA&#8217;s journey over the past half-year has been anything but boring:<\/p>\n<ul>\n<li><strong>January 2025<\/strong>: Started at $8.71, showing early promise<\/li>\n<li><strong>March 2025<\/strong>: Dipped to around $6.50 amid broader biotech sector concerns<\/li>\n<li><strong>May 2025<\/strong>: Recovered to $7.20 on positive clinical trial whispers<\/li>\n<li><strong>July 2025<\/strong>: Hit volatility with options traders betting on big moves<\/li>\n<li><strong>August 2025<\/strong>: Settled at $7.43 after Q2 earnings disappointment<\/li>\n<\/ul>\n<p>The stock has declined 12.2% since January but has shown recent strength with a 22.79% gain over the past month and 36.36% over three months. This recent momentum suggests investors might be anticipating positive developments.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Here&#8217;s where things get exciting for long-term investors. Analyst consensus is overwhelmingly bullish despite recent challenges:<\/p>\n<ul>\n<li><strong>2025 Year-End Target<\/strong>: $24.69 average (222% upside from current price)<\/li>\n<li><strong>2026 Forecast<\/strong>: $28-30 range (continued growth phase)<\/li>\n<li><strong>2028 Projection<\/strong>: $35-40 (potential commercialization phase)<\/li>\n<li><strong>2030 Outlook<\/strong>: $45-50+ (established revenue streams)<\/li>\n<\/ul>\n<p>These projections from <a href=\"https:\/\/stockscan.io\/stocks\/KURA\/forecast\">Stockscan.io<\/a> assume successful clinical trials and regulatory approvals. The most optimistic analysts see $39.19 by December 2025, while conservative estimates hover around $10.19.<\/p>\n<p><strong>Verdict<\/strong>: STRONG BUY for risk-tolerant investors. The analyst consensus of 11 covering firms all rate KURA as &#8220;Buy&#8221; or &#8220;Strong Buy&#8221; with an average price target of $24.45 representing 219% upside potential.<\/p>\n<h2>\u26a0\ufe0f Understanding the Risks vs. Rewards<\/h2>\n<h3>Major Risk Factors<\/h3>\n<ol>\n<li><strong>Clinical Trial Failure<\/strong>: 90% of experimental drugs fail. Negative trial results could crater the stock<\/li>\n<li><strong>Regulatory Hurdles<\/strong>: FDA rejections can instantly destroy billions in market value<\/li>\n<li><strong>Cash Burn<\/strong>: Kura burned $197 million last year with negative profit margins of -236%<\/li>\n<li><strong>Competition<\/strong>: Larger pharma companies with deeper pockets could develop competing treatments<\/li>\n<li><strong>Dilution Risk<\/strong>: May need to raise capital through stock offerings, diluting existing shares<\/li>\n<\/ol>\n<h3>Positive Signals for 2025<\/h3>\n<ol>\n<li><strong>Analyst Consensus<\/strong>: 100% &#8220;Buy&#8221; ratings with no &#8220;Sell&#8221; recommendations<\/li>\n<li><strong>Recent Partnership<\/strong>: Global collaboration with Kyowa Kirin for ziftomenib development<\/li>\n<li><strong>Pipeline Progress<\/strong>: Multiple clinical trials showing promise across different cancer types<\/li>\n<li><strong>Industry Trend<\/strong>: Precision medicine is the future of oncology treatment<\/li>\n<li><strong>Short Interest<\/strong>: Low short interest suggests minimal bearish sentiment<\/li>\n<\/ol>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<p>After analyzing all the data, here&#8217;s my professional advice:<\/p>\n<ol>\n<li><strong>Start Small<\/strong>: Allocate no more than 2-5% of your portfolio to high-risk biotech stocks<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Buy in increments rather than one lump sum to reduce timing risk<\/li>\n<li><strong>Set Stop-Losses<\/strong>: Protect your capital with 15-20% stop-loss orders<\/li>\n<li><strong>Watch November 6th<\/strong>: The Q3 earnings could provide the catalyst for major movement<\/li>\n<\/ol>\n<p>And my humorous take: &#8220;Investing in biotech is like dating &#8211; you might get your heart broken, but when it works, it&#8217;s absolutely magical. Just don&#8217;t bet the wedding money on the first date!&#8221;<\/p>\n<h2>\u2705 How to Buy Kura Oncology, Inc. (KURA) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ listings and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Most platforms require ID and proof of address<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with an amount you&#8217;re comfortable potentially losing<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search for &#8220;KURA&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control your entry price<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review order details<\/td>\n<td>Check commission fees and total cost<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Execute purchase<\/td>\n<td>Confirm your trade and set up price alerts<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Monitor position<\/td>\n<td>Track news and set exit strategies<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Consider tax implications<\/td>\n<td>Understand capital gains treatment<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Reinvest dividends<\/td>\n<td>KURA doesn&#8217;t pay dividends yet, but plan for future income<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for New Investors<\/h2>\n<p>For those looking to dip their toes into biotech investing, Pocket Option offers several advantages that perfectly suit beginner traders:<\/p>\n<ul>\n<li><strong>Minimum deposit of just $5<\/strong> &#8211; You can test strategies with minimal risk<\/li>\n<li><strong>Lightning-fast verification<\/strong> &#8211; Start trading within minutes with simple document upload<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; Access your profits through crypto, e-wallets, or traditional banking<\/li>\n<li><strong>Fractional shares available<\/strong> &#8211; Buy pieces of expensive stocks without full share commitment<\/li>\n<li><strong>Real-time market data<\/strong> &#8211; Make informed decisions with up-to-the-second pricing<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes navigating complex biotech investments much more approachable for newcomers to the stock market.<\/p>\n<h2>\ud83c\udf0d Kura Oncology in 2025: Precision Medicine Pioneer<\/h2>\n<p>Kura Oncology stands at the forefront of cancer treatment innovation. The company develops precision medicines designed to target specific cancer mutations while sparing healthy cells &#8211; think of it as smart bombs versus carpet bombing for cancer treatment.<\/p>\n<p>Their pipeline includes:<\/p>\n<ul>\n<li><strong>Ziftomenib<\/strong>: Menin inhibitor for acute leukemias (partnered with Kyowa Kirin)<\/li>\n<li><strong>Tipifarnib<\/strong>: Farnesyl transferase inhibitor for head and neck cancers<\/li>\n<li><strong>KO-2806<\/strong>: Next-generation cancer treatment in early development<\/li>\n<\/ul>\n<p>The company&#8217;s business model relies heavily on strategic partnerships, with collaboration revenues comprising about 95% of their income according to <a href=\"https:\/\/dcfmodeling.com\/blogs\/history\/kura-history-mission-ownership\">April 2025 data<\/a>. This approach helps share development costs and risk while accelerating time to market.<\/p>\n<p><strong>Interesting Fact for 2025<\/strong>: Kura Oncology&#8217;s CEO, Troy Wilson, was just named an EY Entrepreneur Of The Year 2025 Pacific Southwest Award Winner &#8211; recognition that highlights the company&#8217;s innovative approach and leadership in the competitive biotech landscape. This award often precedes significant corporate developments and increased investor attention.<\/p>\n"},"faq":[{"question":"Is Kura Oncology profitable yet?","answer":"No, Kura is still a clinical-stage company burning through cash for research and development. They reported a net loss of $197 million last year with negative earnings per share of -$2.26."},{"question":"What's the biggest risk with investing in KURA?","answer":"Clinical trial failure is the nuclear bomb risk - negative results can instantly wipe out 50-80% of the stock's value. Always invest only what you can afford to lose completely."},{"question":"When might Kura become profitable?","answer":"Most analysts project 2027-2028 timeframe if their lead drugs receive FDA approval and achieve commercial success. Biotech profitability timelines are notoriously unpredictable."},{"question":"Should I buy before or after earnings on November 6th?","answer":"For beginners, waiting until after earnings reduces risk but may mean missing a potential pop. Consider buying half before and half after to balance FOMO with risk management."},{"question":"What percentage of my portfolio should be in biotech stocks like KURA?","answer":"Most financial advisors recommend limiting speculative biotech investments to 5-10% of your total portfolio due to the extreme volatility and binary outcomes typical in this sector."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is Kura Oncology profitable yet?","answer":"No, Kura is still a clinical-stage company burning through cash for research and development. They reported a net loss of $197 million last year with negative earnings per share of -$2.26."},{"question":"What's the biggest risk with investing in KURA?","answer":"Clinical trial failure is the nuclear bomb risk - negative results can instantly wipe out 50-80% of the stock's value. Always invest only what you can afford to lose completely."},{"question":"When might Kura become profitable?","answer":"Most analysts project 2027-2028 timeframe if their lead drugs receive FDA approval and achieve commercial success. Biotech profitability timelines are notoriously unpredictable."},{"question":"Should I buy before or after earnings on November 6th?","answer":"For beginners, waiting until after earnings reduces risk but may mean missing a potential pop. Consider buying half before and half after to balance FOMO with risk management."},{"question":"What percentage of my portfolio should be in biotech stocks like KURA?","answer":"Most financial advisors recommend limiting speculative biotech investments to 5-10% of your total portfolio due to the extreme volatility and binary outcomes typical in this sector."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Kura Oncology, Inc. (KURA) shares - Investment in Kura Oncology, Inc. (KURA) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Kura Oncology, Inc. (KURA) shares - Investment in Kura Oncology, Inc. (KURA) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T16:02:53+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Kura Oncology, Inc. (KURA) shares &#8211; Investment in Kura Oncology, Inc. (KURA) stock\",\"datePublished\":\"2025-08-25T16:02:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/\",\"name\":\"How to buy Kura Oncology, Inc. (KURA) shares - Investment in Kura Oncology, Inc. (KURA) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-25T16:02:53+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Kura Oncology, Inc. (KURA) shares &#8211; Investment in Kura Oncology, Inc. (KURA) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Kura Oncology, Inc. (KURA) shares - Investment in Kura Oncology, Inc. (KURA) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Kura Oncology, Inc. (KURA) shares - Investment in Kura Oncology, Inc. (KURA) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T16:02:53+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Kura Oncology, Inc. (KURA) shares &#8211; Investment in Kura Oncology, Inc. (KURA) stock","datePublished":"2025-08-25T16:02:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/","name":"How to buy Kura Oncology, Inc. (KURA) shares - Investment in Kura Oncology, Inc. (KURA) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-25T16:02:53+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-kura-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Kura Oncology, Inc. (KURA) shares &#8211; Investment in Kura Oncology, Inc. (KURA) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":348961,"slug":"how-to-buy-kura-oncology","post_title":"Comment acheter des actions de Kura Oncology, Inc. (KURA) - Investir dans les actions de Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-kura-oncology\/"},"it_IT":{"locale":"it_IT","id":348955,"slug":"how-to-buy-kura-oncology","post_title":"Come acquistare azioni Kura Oncology, Inc. (KURA) - Investire in azioni Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-kura-oncology\/"},"pl_PL":{"locale":"pl_PL","id":348956,"slug":"how-to-buy-kura-oncology","post_title":"Jak kupi\u0107 akcje Kura Oncology, Inc. (KURA) - Inwestycja w akcje Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-kura-oncology\/"},"es_ES":{"locale":"es_ES","id":348960,"slug":"how-to-buy-kura-oncology","post_title":"C\u00f3mo comprar acciones de Kura Oncology, Inc. (KURA) - Inversi\u00f3n en acciones de Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-kura-oncology\/"},"th_TH":{"locale":"th_TH","id":348962,"slug":"how-to-buy-kura-oncology","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Kura Oncology, Inc. (KURA) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-kura-oncology\/"},"tr_TR":{"locale":"tr_TR","id":348957,"slug":"how-to-buy-kura-oncology","post_title":"Kura Oncology, Inc. (KURA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Kura Oncology, Inc. (KURA) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-kura-oncology\/"},"vt_VT":{"locale":"vt_VT","id":348959,"slug":"how-to-buy-kura-oncology","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Kura Oncology, Inc. (KURA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-kura-oncology\/"},"pt_AA":{"locale":"pt_AA","id":348958,"slug":"how-to-buy-kura-oncology","post_title":"Como comprar a\u00e7\u00f5es da Kura Oncology, Inc. (KURA) - Investimento em a\u00e7\u00f5es da Kura Oncology, Inc. (KURA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-kura-oncology\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/348880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=348880"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/348880\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=348880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=348880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=348880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}